Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BCL7A
REST API REST API
Homo sapiens
BCL7A is differentially expressed in 294 experiments: 126 organism parts: brain, cerebellum, ... (124 more);, 188 disease states: normal, glioblastoma, ... (186 more);, 102 cell types 455 cell lines 36 compound treatments and 66 other conditions.
Synonyms BCL7
Orthologs Bcl7a (Mus musculus)   BCL7A (Gallus gallus)   D3ZI21_RAT (Rattus norvegicus)   BCL7A (Bos taurus)   bcl7a (Danio rerio)   ENSCING00000008833 (Ciona intestinalis)   BCL7-like (Drosophila melanogaster)   bcl7a (Xenopus laevis)   BCL7A (Canis familiaris)   (Compare orthologs)
Gene Ontology Term negative regulation of transcription, DNA-dependent, molecular_function, cellular_component
UniProt Accession Q4VC05
InterPro Term BCL7
Search EB-eye ENSG00000110987
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (28 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-4717, ... (41 experiments)

Factor Value U/D Experiments
BT474
3
E-MEXP-440, E-MTAB-62, E-MTAB-37
MCF-7
3
E-GEOD-3529, E-GEOD-19639, E-GEOD-20081
SW480
3
E-MEXP-1014, E-MTAB-37, E-GEOD-18005
HL-60
2
E-GEOD-24147, E-GEOD-5258
LNCaP
2
E-GEOD-14464, E-GEOD-14990
Jurkat
2
E-GEOD-1880, E-MTAB-62
449 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-GEOD-20677, E-GEOD-2822, E-GEOD-21750, ... (51 experiments)

Factor Value U/D Experiments
CD19+ B cells (neg. sel.)
2
E-AFMX-5, E-TABM-145
CD8+ T cell
2
E-AFMX-5, E-TABM-145
fibroblast
2
E-GEOD-3204, E-GEOD-3920
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18265
stromal cell
1
2
E-MEXP-2034, E-GEOD-1460, E-GEOD-10797
B cell
1
2
1
E-GEOD-13987, E-GEOD-7307, E-GEOD-3982
96 more value(s).


Disease state

studied in E-GEOD-3307, E-MEXP-1121, E-TABM-15, E-MEXP-2280, E-MTAB-62, ... (68 experiments)

Factor Value U/D Experiments
glioblastoma
4
E-GEOD-4290, E-MTAB-37, E-GEOD-4412, E-MTAB-62
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
osteosarcoma
2
E-MTAB-37, E-MTAB-62
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
neuroblastoma
2
E-MTAB-37, E-MTAB-62
rhabdomyosarcoma
2
E-MTAB-62, E-MTAB-37
182 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-15205, E-GEOD-5824, E-GEOD-5099, E-GEOD-6462, ... (20 experiments)

Factor Value U/D Experiments
interleukin-4 (Homo sapiens)
1
E-GEOD-5099
dimethyl sulfoxide
1
E-GEOD-5824
control for EGF
1
E-GEOD-6462
anti-CD3 + anti-CD28
1
E-GEOD-7307
hydroxyurea
1
E-GEOD-6431
5-aza-2'-deoxycytidine
3
1
E-MEXP-1269
30 more value(s).


Age at onset

studied in E-GEOD-21521

Factor Value U/D Experiments
GTE6
1
E-GEOD-21521
LT6
1
E-GEOD-21521


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd3
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-2171, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (8 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-GEOD-2666, ... (6 experiments)

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-MEXP-2280, E-TABM-147, E-GEOD-21138 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-7578, E-GEOD-6431, E-MEXP-2340 ... (5 experiments)

Genotype
studied in E-TABM-763, E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, E-TABM-321, ... (11 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-13073, E-MEXP-1220, E-GEOD-6432, E-GEOD-5681, E-MEXP-2657, ... (10 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-974, E-GEOD-2466, E-MEXP-2069, ... (36 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980, ... (6 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-MEXP-958, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-26495, E-GEOD-4525, E-GEOD-19703, E-GEOD-1309, E-GEOD-21750, ... (8 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19445, ... (7 experiments)

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276, E-GEOD-2748

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22369, E-GEOD-33562, E-GEOD-22368, E-MEXP-973, E-GEOD-19246 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-4922

Processing time: 0.42 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM